Pathogenic Variants of Ornithine Transcarbamylase Deficiency: Nation-wide Study in Japan and Literature Review

Overview

Journal Front Genet

Date 2022 Oct 28

PMID 36303552

Authors

Jun Kido

Keishin Sugawara

Takaaki Sawada

Shirou Matsumoto

Kimitoshi Nakamura

Affiliations

Soon will be listed here.

Abstract

Ornithine transcarbamylase deficiency (OTCD) is an X-linked disorder. Several male patients with OTCD suffer from severe hyperammonemic crisis in the neonatal period, whereas others develop late-onset manifestations, including hyperammonemic coma. Females with heterozygous pathogenic variants in the gene may develop a variety of clinical manifestations, ranging from asymptomatic conditions to severe hyperammonemic attacks, owing to skewed lyonization. We reported the variants of , , and detected in the patients with urea cycle disorders through a nation-wide survey in Japan. In this study, we updated the variant data of in Japanese patients and acquired information regarding genetic variants of from patients with OTCD through an extensive literature review. The 523 variants included 386 substitution (330 missense, 53 nonsense, and 3 silent), eight deletion, two duplication, one deletion-insertion, 55 frame shift, two extension, and 69 no category (1 regulatory and 68 splice site error) mutations. We observed a genotype-phenotype relation between the onset time (neonatal onset or late onset), the severity, and genetic mutation in male OTCD patients because the level of deactivation of significantly depends on the pathogenic OTC variants. In conclusion, genetic information about may help to predict long-term outcomes and determine specific treatment strategies, such as liver transplantation, in patients with OTCD.

Citing Articles

Neonatal Presentation of Ornithine Transcarbamylase Deficiency Associated With a Hypomorphic OTC Variant (p.Leu301Phe) Previously Reported in Later-Onset Disease.

Anderson S, Ciarlariello M, Botti C, Velinov M Cureus. 2024; 16(8):e65956.

PMID: 39221296 PMC: 11365575. DOI: 10.7759/cureus.65956.

References

Climent C, Rubio V . Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency. Hum Mutat. 2002; 19(2):185-6. DOI: 10.1002/humu.9011. View

Rapp B, Haberle J, Linnebank M, Wermuth B, Marquardt T, Harms E . Genetic analysis of carbamoylphosphate synthetase I and ornithine transcarbamylase deficiency using fibroblasts. Eur J Pediatr. 2001; 160(5):283-7. DOI: 10.1007/s004310100725. View

Qin L, Wang J, Tian X, Yu H, Truong C, Mitchell J . Detection and Quantification of Mosaic Mutations in Disease Genes by Next-Generation Sequencing. J Mol Diagn. 2016; 18(3):446-453. DOI: 10.1016/j.jmoldx.2016.01.002. View

Kido J, Matsumoto S, Mitsubuchi H, Endo F, Nakamura K . Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment. Metab Brain Dis. 2018; 33(5):1517-1523. DOI: 10.1007/s11011-018-0259-6. View

Matsuura T, Hoshide R, Kiwaki K, Komaki S, Koike E, Endo F . Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early-onset OTC deficiency. Hum Mutat. 1994; 3(4):402-6. DOI: 10.1002/humu.1380030415. View

Shi D, Morizono H, Ha Y, Aoyagi M, Tuchman M, Allewell N . 1.85-A resolution crystal structure of human ornithine transcarbamoylase complexed with N-phosphonacetyl-L-ornithine. Catalytic mechanism and correlation with inherited deficiency. J Biol Chem. 1998; 273(51):34247-54. DOI: 10.1074/jbc.273.51.34247. View

Yamaguchi S, Brailey L, Morizono H, Bale A, Tuchman M . Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum Mutat. 2006; 27(7):626-32. DOI: 10.1002/humu.20339. View

Yoo H, Kim G, Lee D . Identification of new mutations in the ornithine transcarbamylase (OTC) gene in Korean families. J Inherit Metab Dis. 1996; 19(1):31-42. DOI: 10.1007/BF01799346. View

Tuchman M, Morizono H, Reish O, Yuan X, Allewell N . The molecular basis of ornithine transcarbamylase deficiency: modelling the human enzyme and the effects of mutations. J Med Genet. 1995; 32(9):680-8. PMC: 1051666. DOI: 10.1136/jmg.32.9.680. View

10.

Balasubramaniam S, Rudduck C, Bennetts B, Peters G, Wilcken B, Ellaway C . Contiguous gene deletion syndrome in a female with ornithine transcarbamylase deficiency. Mol Genet Metab. 2009; 99(1):34-41. DOI: 10.1016/j.ymgme.2009.08.007. View

11.

Zimmer K, Matsuura T, COLOMBO J, Koch H, Ullrich K, Deufel T . A novel point mutation at codon 269 of the ornithine transcarbamylase (OTC) gene causing neonatal onset of OTC deficiency. J Inherit Metab Dis. 1995; 18(3):356-7. DOI: 10.1007/BF00710430. View

12.

Fantur M, Karall D, Scholl-Buergi S, Haberle J, Rauchenzauner M, Fruehwirth M . Recurrent somnolence in a 17-month-old infant: late-onset ornithine transcarbamylase (OTC) deficiency due to the novel hemizygous mutation c.535C > T (p.Leu179Phe). Eur J Paediatr Neurol. 2012; 17(1):112-5. DOI: 10.1016/j.ejpn.2012.05.007. View

13.

Shchelochkov O, Li F, Geraghty M, Gallagher R, Van Hove J, Lichter-Konecki U . High-frequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (OTC) locus by oligonucleotide array CGH. Mol Genet Metab. 2009; 96(3):97-105. DOI: 10.1016/j.ymgme.2008.11.167. View

14.

Maddalena A, Spence J, OBrien W, Nussbaum R . Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency. J Clin Invest. 1988; 82(4):1353-8. PMC: 442691. DOI: 10.1172/JCI113738. View

15.

Zhou Q, Huang H, Ma L, Zhu T . The Application of Next-Generation Sequencing (NGS) in Neonatal-Onset Urea Cycle Disorders (UCDs): Clinical Course, Metabolomic Profiling, and Genetic Findings in Nine Chinese Hyperammonemia Patients. Biomed Res Int. 2020; 2020:5690915. PMC: 7479453. DOI: 10.1155/2020/5690915. View

16.

Hata A, Matsuura T, Setoyama C, Shimada K, Yokoi T, AKABOSHI I . A novel missense mutation in exon 8 of the ornithine transcarbamylase gene in two unrelated male patients with mild ornithine transcarbamylase deficiency. Hum Genet. 1991; 87(1):28-32. DOI: 10.1007/BF01213087. View

17.

Ensenauer R, Tuchman M, El-Youssef M, Kotagal S, Ishitani M, Matern D . Management and outcome of neonatal-onset ornithine transcarbamylase deficiency following liver transplantation at 60 days of life. Mol Genet Metab. 2005; 84(4):363-6. DOI: 10.1016/j.ymgme.2004.12.011. View

18.

Genet S, Cranston T . Mutation detection in 65 families with a possible diagnosis of ornithine carbamoyltransferase deficiency including 14 novel mutations. J Inherit Metab Dis. 2000; 23(7):669-76. DOI: 10.1023/a:1005614409241. View

19.

Bijarnia-Mahay S, Haberle J, Jalan A, Puri R, Kohli S, Kudalkar K . Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing. Orphanet J Rare Dis. 2018; 13(1):174. PMC: 6167905. DOI: 10.1186/s13023-018-0908-1. View

20.

Mukhtar A, Dabbous H, El Sayed R, Aboulfetouh F, Bahaa M, Abdelaal A . A novel mutation of the ornithine transcarbamylase gene leading to fatal hyperammonemia in a liver transplant recipient. Am J Transplant. 2013; 13(4):1084-1087. DOI: 10.1111/ajt.12146. View